3 ms·
There are two types of risks in this field: 1. Approve something too soon. This kills/hurts patients using it. 2. Wait too long approving something. This kill
by BurningFrog 6y ago
There are two types of risks in this field:
1. Approve something too soon. This kills/hurts patients using it.
2. Wait too long approving something. This kills/hurts sick people who are deprived of good treatment.
The classic big FDA flaw is to heavily lean towards type 2 errors, because type 1 deaths lead to bad PR, while no one notices type 2 errors.
So that EMA apparently made a type 1 error here is possibly a good sign!
- JediWing 6y agoIt's worth noting that in medical culture, knowingly implementing a process that does not aim to eliminate all type #1 errors as much as possible would violate the spirit of the Hippocratic oath, whereas #2 would not.